Featured Research

from universities, journals, and other organizations

New nanoscale imaging may lead to new treatments for multiple sclerosis

Date:
May 27, 2011
Source:
University of California - Santa Barbara
Summary:
Laboratory studies by chemical engineers may lead to new experimental methods for early detection and diagnosis -- and to possible treatments -- for pathological tissues that are precursors to multiple sclerosis and similar diseases.

These are fluorescence images of lipid domains in model (laboratory reconstituted) myelin monolayers showing coexistence of liquid-ordered (dark) and liquid-disordered (pseudo-colored) phases. Depending on the conditions (e.g., liquid-disordered (pseudo-colored) phases. Depending on the conditions (e.g., lipid composition, surface pressure, temperature), the lipid domains can exist in various shapes including striped (left) and circular (right).
Credit: Images courtesy of Younjin Min, Massachusetts Institute of Technology

Laboratory studies by chemical engineers at UC Santa Barbara may lead to new experimental methods for early detection and diagnosis -- and to possible treatments -- for pathological tissues that are precursors to multiple sclerosis and similar diseases.

Achieving a new method of nanoscopic imaging, the scientific team studied the myelin sheath, the membrane surrounding nerves that is compromised in patients with multiple sclerosis (MS).

The study is published in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS).

"Myelin membranes are a class of biological membranes that are only two molecules thick, less than one millionth of a millimeter," said Jacob Israelachvili, one of the senior authors and professor of chemical engineering and of materials at UCSB. "The membranes wrap around the nerve axons to form the myelin sheath."

He explained that the way different parts of the central nervous system, including the brain, communicate with each other throughout the body is via the transmission of electric impulses, or signals, along the fibrous myelin sheaths. The sheaths act like electric cables or transmission lines.

"Defects in the molecular or structural organization of myelin membranes lead to reduced transmission efficiency," said Israelachvilli. "This results in various sensory and motor disorders or disabilities, and neurological diseases such as multiple sclerosis."

At the microscopic level and the macroscopic level, which is visible to the eye, MS is characterized by the appearance of lesions or vacuoles in the myelin, and eventually results in the complete disintegration of the myelin sheath. This progressive disintegration is called demyelination.

The researchers focused on what happens at the molecular level, commonly referred to as the nanoscopic level. This requires highly sensitive visualization and characterization techniques.

The article describes fluorescence imaging and other measurements of domains, which are small heterogeneous clusters of lipid molecules -- the main constituents of myelin membranes -- that are likely to be responsible for the formation of lesions. They did this using model molecular layers in compositions that mimic both healthy and diseased myelin membranes.

They observed differences in the appearance, size, and sensitivity to pressure, of domains in the healthy and diseased monolayers. Next, they developed a theoretical model, in terms of certain molecular properties, that appears to account quantitatively for their observations.

"The discovery and characterization of micron-sized domains that are different in healthy and diseased lipid assemblies have important implications for the way these membranes interact with each other," said Israelachvili. "And this leads to new understanding of demyelination at the molecular level."

The findings pave the way for new experimental methods for early detection, diagnosis, staging, and possible treatment of pathological tissues that are precursors to MS and other membrane-associated diseases, according to the authors.

All of the work reported in the paper was completed at UCSB, although some of the authors have moved to other institutions. In addition to Israelachvili, the other authors are Dong Woog Lee, graduate student in UCSB's Department of Chemical Engineering; Younjin Min, now a postdoctoral fellow in the Department of Chemical Engineering at the Massachusetts Institute of Engineering; Prajnaparamitra Dhar, now assistant professor in the Department of Chemical Engineering at the University of Kansas; Arun Ramachandran, now assistant professor in the Department of Chemical Engineering and Applied Chemistry at the University of Toronto; and Joseph A. Zasadzinski, now professor in the Department of Chemical Engineering and Materials Science at the University of Minnesota.


Story Source:

The above story is based on materials provided by University of California - Santa Barbara. Note: Materials may be edited for content and length.


Journal Reference:

  1. Dong Woog Lee, Younjin Min, Prajnaparamitra Dhar, Arun Ramachandran, Jacob N. Israelachvili and Joseph A. Zasadzinski. Relating domain size distribution to line tension and molecular dipole density in model cytoplasmic myelin lipid monolayers. PNAS, May 23, 2011 DOI: 10.1073/pnas.1106368108

Cite This Page:

University of California - Santa Barbara. "New nanoscale imaging may lead to new treatments for multiple sclerosis." ScienceDaily. ScienceDaily, 27 May 2011. <www.sciencedaily.com/releases/2011/05/110523152348.htm>.
University of California - Santa Barbara. (2011, May 27). New nanoscale imaging may lead to new treatments for multiple sclerosis. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/05/110523152348.htm
University of California - Santa Barbara. "New nanoscale imaging may lead to new treatments for multiple sclerosis." ScienceDaily. www.sciencedaily.com/releases/2011/05/110523152348.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins